The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase III study of panobinostat with bortezomib and dexamethasone in patients with relapsed multiple myeloma (PANORAMA 1).
Jesùs F. San-Miguel
Consultant or Advisory Role - Novartis; Novartis
Honoraria - Novartis; Novartis
Philippe Moreau
Honoraria - Novartis
Sung-Soo Yoon
No relevant relationships to disclose
Meletios A. Dimopoulos
Consultant or Advisory Role - Novartis; Ortho Biotech
Honoraria - Novartis; Ortho Biotech
Vânia Tietsche de Moraes Hungria
No relevant relationships to disclose
Wieslaw W. Jedrzejczak
Honoraria - Novartis
Research Funding - Novartis
Other Remuneration - Novartis
Ashraf el Ghandour
No relevant relationships to disclose
Paolo Corradini
Honoraria - Celgene; Genzyme; Novartis
Andreas Günther
Research Funding - Novartis
Expert Testimony - Novartis
Meral Beksac
Honoraria - Janssen-Cilag
Kwee Yong
Honoraria - Celgene; Janssen-Cilag
Jae Hoon Lee
No relevant relationships to disclose
Sagar Lonial
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx
Research Funding - Bristol-Myers Squibb; Celgene; Merck; Millennium; Novartis; Onyx
Jian Hou
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Hermann Einsele
Consultant or Advisory Role - Novartis
Monika M Wroclawska-Swacha
Employment or Leadership Position - Novartis
Hans-Jochen Weber
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Priscille M. Bourquelot
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
Paul Gerard Guy Richardson
Consultant or Advisory Role - Celgene; Johnson & Johnson; Millennium; Novartis